Cochrane Review: Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease

Zusammenfassung

Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease - Chung, EYM - 2020 \| Cochrane Library [Skip to Content](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007004.pub4/full/de#main-content) [Close cookies message](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007004.pub4/full/de#) Cookies Our site uses cookies to improve your experience. You can find out more about our use of cookies

Kerninformationen

.1002/14651858.CD007004.pub4/full/de#) [Cochrane Database of Systematic reviews](https://www.cochranelibrary.com/en/about/about-cochrane-reviews) Review - Intervention - [New search](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007004.pub4/information/de#history) Collapse all Expa...

### Objectives To evaluate the effects of aldosterone antagonists (selective (eplerenone), non‐selective (spironolactone or canrenone), or non‐steroidal mineralocorticoid antagonists (finerenone)) in adults who have CKD with proteinuria (nephrotic and non‐nephrotic range) on: patient‐centred endpo...

alist using search terms relevant to this review. Studies in the Register are identified through searches of CENTRAL, MEDLINE, and EMBASE, conference proceedings, the International Clinical Trials Register (ICTRP) Search Portal, and ClinicalTrials.gov. ### Selection criteria We included randomised...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen